Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7415 | 1370 | 55.1 | 95% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
140 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY | 23462 |
7415 | 1 | MYELOID DERIVED SUPPRESSOR CELLS//MDSC//MYELOID DERIVED SUPPRESSOR CELLS MDSC | 1370 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MYELOID DERIVED SUPPRESSOR CELLS | authKW | 4427547 | 23% | 62% | 318 |
2 | MDSC | authKW | 1036087 | 8% | 42% | 111 |
3 | MYELOID DERIVED SUPPRESSOR CELLS MDSC | authKW | 465583 | 2% | 67% | 31 |
4 | MDSCS | authKW | 445994 | 3% | 51% | 39 |
5 | TUMOR INDUCED IMMUNE SUPPRESSION | authKW | 109202 | 1% | 70% | 7 |
6 | IMMATURE MYELOID CELLS | authKW | 83998 | 1% | 54% | 7 |
7 | MYELOID DERIVED SUPPRESSOR CELL MDSC | authKW | 80228 | 0% | 60% | 6 |
8 | IMMUNE SUPPRESSION | authKW | 67937 | 4% | 6% | 50 |
9 | G MDSC | authKW | 66861 | 0% | 100% | 3 |
10 | INFECT INFLAMMATORY IMMUNOL DIS | address | 66861 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 13934 | 48% | 0% | 661 |
2 | Oncology | 7669 | 39% | 0% | 537 |
3 | Hematology | 786 | 8% | 0% | 110 |
4 | Medicine, Research & Experimental | 781 | 10% | 0% | 136 |
5 | Cell Biology | 591 | 12% | 0% | 170 |
6 | Transplantation | 64 | 2% | 0% | 25 |
7 | Gastroenterology & Hepatology | 48 | 3% | 0% | 36 |
8 | Rheumatology | 7 | 1% | 0% | 10 |
9 | Cell & Tissue Engineering | 7 | 0% | 0% | 4 |
10 | Pathology | 4 | 1% | 0% | 17 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INFECT INFLAMMATORY IMMUNOL DIS | 66861 | 0% | 100% | 3 |
2 | MED MICROBIOL TUMOR VIROL CANC IMMUNOTHERA | 50144 | 0% | 75% | 3 |
3 | ISRAEL CANADA MED | 46425 | 0% | 42% | 5 |
4 | KINDERKLIN MUNCHEN WABING PEDIAT | 44574 | 0% | 100% | 2 |
5 | PLURIDISCIPLINIAIRE ONCOL CEPO | 44574 | 0% | 100% | 2 |
6 | AFFILIATED GUANGZHOU WOMEN CHILDRENS MED | 42853 | 0% | 38% | 5 |
7 | GI MALIGNANCY SECT | 40114 | 0% | 60% | 3 |
8 | PERITONEAL OVARIAN CANC SPECIALTY CARE | 40114 | 0% | 60% | 3 |
9 | JIANGSU MED | 32768 | 0% | 29% | 5 |
10 | ONCOL IMMUNOL SECT | 32768 | 0% | 29% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOIMMUNOLOGY | 41086 | 3% | 4% | 42 |
2 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 19037 | 4% | 1% | 61 |
3 | CANCER IMMUNOLOGY RESEARCH | 9702 | 1% | 3% | 14 |
4 | JOURNAL OF IMMUNOLOGY | 6503 | 9% | 0% | 126 |
5 | JOURNAL OF LEUKOCYTE BIOLOGY | 5593 | 3% | 1% | 42 |
6 | CANCER RESEARCH | 3744 | 6% | 0% | 82 |
7 | INTERNATIONAL IMMUNOPHARMACOLOGY | 3447 | 2% | 1% | 26 |
8 | IMMUNOTHERAPY | 3076 | 1% | 1% | 10 |
9 | IMMUNOLOGICAL INVESTIGATIONS | 2545 | 1% | 1% | 13 |
10 | FRONTIERS IN IMMUNOLOGY | 2457 | 1% | 1% | 18 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MYELOID DERIVED SUPPRESSOR CELLS | 4427547 | 23% | 62% | 318 | Search MYELOID+DERIVED+SUPPRESSOR+CELLS | Search MYELOID+DERIVED+SUPPRESSOR+CELLS |
2 | MDSC | 1036087 | 8% | 42% | 111 | Search MDSC | Search MDSC |
3 | MYELOID DERIVED SUPPRESSOR CELLS MDSC | 465583 | 2% | 67% | 31 | Search MYELOID+DERIVED+SUPPRESSOR+CELLS+MDSC | Search MYELOID+DERIVED+SUPPRESSOR+CELLS+MDSC |
4 | MDSCS | 445994 | 3% | 51% | 39 | Search MDSCS | Search MDSCS |
5 | TUMOR INDUCED IMMUNE SUPPRESSION | 109202 | 1% | 70% | 7 | Search TUMOR+INDUCED+IMMUNE+SUPPRESSION | Search TUMOR+INDUCED+IMMUNE+SUPPRESSION |
6 | IMMATURE MYELOID CELLS | 83998 | 1% | 54% | 7 | Search IMMATURE+MYELOID+CELLS | Search IMMATURE+MYELOID+CELLS |
7 | MYELOID DERIVED SUPPRESSOR CELL MDSC | 80228 | 0% | 60% | 6 | Search MYELOID+DERIVED+SUPPRESSOR+CELL+MDSC | Search MYELOID+DERIVED+SUPPRESSOR+CELL+MDSC |
8 | IMMUNE SUPPRESSION | 67937 | 4% | 6% | 50 | Search IMMUNE+SUPPRESSION | Search IMMUNE+SUPPRESSION |
9 | G MDSC | 66861 | 0% | 100% | 3 | Search G+MDSC | Search G+MDSC |
10 | MONOCYTIC MDSC | 66861 | 0% | 100% | 3 | Search MONOCYTIC+MDSC | Search MONOCYTIC+MDSC |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GABRILOVICH, DI , NAGARAJ, S , (2009) MYELOID-DERIVED SUPPRESSOR CELLS AS REGULATORS OF THE IMMUNE SYSTEM.NATURE REVIEWS IMMUNOLOGY. VOL. 9. ISSUE 3. P. 162 -174 | 86 | 66% | 2065 |
2 | PARKER, KH , BEURY, DW , OSTRAND-ROSENBERG, S , (2015) MYELOID-DERIVED SUPPRESSOR CELLS: CRITICAL CELLS DRIVING IMMUNE SUPPRESSION IN THE TUMOR MICROENVIRONMENT.IMMUNOTHERAPY OF CANCER. VOL. 128. ISSUE . P. 95 -139 | 133 | 72% | 34 |
3 | MARVEL, D , GABRILOVICH, DI , (2015) MYELOID-DERIVED SUPPRESSOR CELLS IN THE TUMOR MICROENVIRONMENT: EXPECT THE UNEXPECTED.JOURNAL OF CLINICAL INVESTIGATION. VOL. 125. ISSUE 9. P. 3356 -3364 | 90 | 78% | 68 |
4 | GABRILOVICH, DI , OSTRAND-ROSENBERG, S , BRONTE, V , (2012) COORDINATED REGULATION OF MYELOID CELLS BY TUMOURS.NATURE REVIEWS IMMUNOLOGY. VOL. 12. ISSUE 4. P. 253 -268 | 96 | 49% | 826 |
5 | PYZER, AR , COLE, L , ROSENBLATT, J , AVIGAN, DE , (2016) MYELOID-DERIVED SUPPRESSOR CELLS AS EFFECTORS OF IMMUNE SUPPRESSION IN CANCER.INTERNATIONAL JOURNAL OF CANCER. VOL. 139. ISSUE 9. P. 1915 -1926 | 142 | 71% | 3 |
6 | DE SANCTIS, F , SOLITO, S , UGEL, S , MOLON, B , BRONTE, V , MARTO, I , (2016) MDSCS IN CANCER: CONCEIVING NEW PROGNOSTIC AND THERAPEUTIC TARGETS.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1865. ISSUE 1. P. 35 -48 | 125 | 69% | 5 |
7 | MOTALLEBNEZHAD, M , JADIDI-NIARAGH, F , QAMSARI, ES , BAGHERI, S , GHARIBI, T , YOUSEFI, M , (2016) THE IMMUNOBIOLOGY OF MYELOID-DERIVED SUPPRESSOR CELLS IN CANCER.TUMOR BIOLOGY. VOL. 37. ISSUE 2. P. 1387 -1406 | 137 | 66% | 4 |
8 | SOLITO, S , MARIGO, I , PINTON, L , DAMUZZO, V , MANDRUZZATO, S , BRONTE, V , (2014) MYELOID-DERIVED SUPPRESSOR CELL HETEROGENEITY IN HUMAN CANCERS.YEAR IN IMMUNOLOGY: MYELOID CELLS AND INFLAMMATION. VOL. 1319. ISSUE . P. 47 -65 | 98 | 81% | 64 |
9 | CONDAMINE, T , RAMACHANDRAN, I , YOUN, JI , GABRILOVICH, DI , (2015) REGULATION OF TUMOR METASTASIS BY MYELOID-DERIVED SUPPRESSOR CELLS.ANNUAL REVIEW OF MEDICINE, VOL 66. VOL. 66. ISSUE . P. 97 -110 | 76 | 82% | 40 |
10 | POSCHKE, I , KIESSLING, R , (2012) ON THE ARMAMENT AND APPEARANCES OF HUMAN MYELOID-DERIVED SUPPRESSOR CELLS.CLINICAL IMMUNOLOGY. VOL. 144. ISSUE 3. P. 250-268 | 107 | 74% | 63 |
Classes with closest relation at Level 1 |